SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
443.00    10.00 (2.31%)
Bid:
440.00
Ask:
443.00
Spread: 3.00 (0.682%)
Market Cap: £218.72m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Trading Update

14 Jan 2020 07:00

RNS Number : 6507Z
City of London Investment Group PLC
14 January 2020
 

 

City of London Investment Group PLC

14 January 2020



CITY OF LONDON INVESTMENT GROUP PLC

("City of London", "the Group" or "the Company")

 

FUNDS UNDER MANAGEMENT AS AT 31 December 2019,

TRADING UPDATE

 

City of London (LSE: CLIG), a leading specialist asset management group offering a range of institutional products investing in closed-end funds, announces that as at 31 December 2019, FuM were US$6 billion (£4.5 billion). This compares with US$5.4 billion (£4.3 billion) at the Company's year-end on 30 June 2019. A breakdown by strategy follows:

 

 

FuM ($mn)

 

 

 

Strategy Index

 

 

 

 

 

 

 

 

 

 

 

 

 

Dec-19

Jun-19

%

 

Net

 

 

 

%

 

(estimate)

inc/dec

 

Flows

 

 

 

inc/dec

EM

4,429

4,221

5%

 

(118)

 

MSCI EM

 

7%

DEV

1,109

729

52%

 

272

 

MSCI ACWI

 

7%

Opportunistic Value

270

233

16%

 

20

 

ACWI/Barclays Global Agg

 

5%

Frontier

206

206

0%

 

8

 

S&P Frontier 150

 

0%

 

6,014

5,389

 

 

182

 

 

 

 

 Excludes seed investments

 

The EM and International Developed strategies outperformed, driven by narrower discounts, positive country allocation and good NAV performance. The Opportunistic Value Strategy outperformed led by good NAV performance and significant discount narrowing. The Frontier strategy underperformed due primarily to negative country allocation and discount widening.

 

During the period under review, the Developed strategies recorded net inflows of $272 million. The EM strategies saw net outflows of $118 million. We have to date received notification of circa $200 million of net inflows in aggregate across all strategies, which we expect to fund over the next quarter.

 

With regard to business development, the Group continues to maintain an active pipeline across all of its major CEF offerings with an increased interest in the diversification CEF strategies. 

 

Operations

 

The Group's income currently accrues at a weighted average rate of approximately 75 basis points of FuM, net of third party commissions. "Fixed" costs are c£1.1 million per month, and accordingly the current run-rate for operating profit, before profit-share of 30% and an EIP charge of 5%, is approximately £1.8 million per month based upon current FuM and a US$/£ exchange rate of US$1.3257 to £1 as at 31 December 2019.

 

The Group estimates the unaudited profit before taxation for the six months ended 31 December 2019 to be approximately £6.3 million, which compares with £5.2 million for the equivalent period to 31 December 2018.

 

The Company is currently in a close period which will end with the publication of results for the six months ended 31 December 2019 on 17 February 2020.

 

Dividend

 

In recognition of the improved results and having regard to the current dividend cover policy the Board has decided to increase the interim dividend by 1p to 10p per share, which will be paid on 20 March 2020 to shareholders registered at the close of business on 6 March 2020 (2019: 9 pence).

 

Template

 

Please see the attached graph which is based on the following assumptions and includes the estimated quarterly cost of the dividend:

 

http://www.rns-pdf.londonstockexchange.com/rns/6507Z_1-2020-1-13.pdf

 

Key assumptions:

 

(June 2019 comparatives in Italics)

 

-

Starting point Current FuM (end December 2019)

-

Net increase for the remainder of this financial year (straight-lined to June 2020):

- emerging market CEF strategy zero (zero)

- non-emerging market CEF strategies US$250 (US$250m over the full year)

-

Net increase in 2020/2021 (straight-lined to June 2021):

- emerging market CEF strategy zero

- non-emerging market CEF strategies US$250m

-

Operating margin adjusted monthly for change in product mix and commission run-off

-

Market growth: 0%

-

Overheads for 2019/20: no increase on 2018/2019 (0%)

-

Overheads for 2020/21: +3% compared with 2018/2019

-

EIP cost for 2019/20: 5% of operating profit (5%)

-

EIP cost for 2020/21: n/a now falls within 30% profit-share

-

Corporation tax based on an estimated average rate of 21% (21%)

-

Exchange rate assumed to be £1/$1.31 for entire period (£1/US$1.27)

-

Number of CLIG Shares in issue (26.6m) less those held by the ESOP Trust (1.7m) as at 31 December 2019 (26.6 m CLIG shares in issue less 1.5m ESOP Trust holding)

 

For further information, please visit http://www.citlon.co.uk/ or contact:

 

Tom Griffith, CEO

City of London Investment Group PLC

Tel: 001-610-380-0435

 

Martin Green

Zeus Capital Limited

Financial Adviser & Broker

Tel: +44 (0)20 3829 5000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFSFMDESSESF
Date   Source Headline
21st Jan 20193:50 pmEQSHardman & Co Research: City of London Investment Group (CLIG): Solid FUM update offset by margin changes
16th Jan 20197:00 amRNSFUNDS UNDER MANAGEMENT - Trading Update
30th Oct 20184:48 pmRNSDirector/PDMR Shareholding
30th Oct 20184:47 pmRNSDirector/PDMR Shareholding
30th Oct 20184:46 pmRNSDirector/PDMR Shareholding
22nd Oct 20183:27 pmRNSResult of AGM
17th Oct 201811:37 amRNSHolding(s) in Company
9th Oct 20183:05 pmEQSHardman & Co Research: City of London Investment Group (CLIG): Solid FUM update offset by margin changes
8th Oct 20187:00 amRNSTrading Update - 1st Quarter FuM
25th Sep 201811:17 amRNSHolding(s) in Company
25th Sep 20187:00 amRNSDirector/PDMR Shareholding
20th Sep 20181:46 pmEQSHardman & Co Research: City of London Investment Group (CLIG): Strengthening cash position to boost returns
17th Sep 20183:15 pmRNSFinal Results - Replacement
17th Sep 20187:00 amRNSInterim Results
14th Aug 20183:39 pmRNSTEXT OF LETTER TO LAZARD WORLD TRUST FUND
9th Aug 20182:58 pmRNSShare Buyback and Total Voting Rights
17th Jul 201810:55 amEQSHardman & Co Research: City of London Investment Group (CLIG): Dividend increase boosts yield
17th Jul 20187:00 amRNSTrading Update
11th Jul 201811:39 amRNSDirector Declaration
4th Jul 20183:48 pmRNSHolding(s) in Company
14th Jun 201811:25 amRNSHolding(s) in Company
29th May 20184:57 pmRNSHolding(s) in Company
10th May 20185:25 pmRNSHolding(s) in Company
1st May 20187:00 amRNSBoard Changes
25th Apr 20184:34 pmRNSHolding(s) in Company
18th Apr 20187:00 amRNSInterim Management Statement / Trading Update
3rd Apr 20184:03 pmRNSHolding(s) in Company
23rd Mar 20189:46 amRNSDirector/PDMR Shareholding
14th Mar 20183:41 pmRNSDirector/PDMR Shareholding
19th Feb 20187:00 amRNSInterim Results
18th Jan 201810:02 amRNSNew Directorship notification Listing Rule 9.6.14
17th Jan 20187:00 amRNSTrading Update
21st Dec 20172:24 pmRNSHolding(s) in Company
8th Dec 20176:36 pmRNSHolding(s) in Company
6th Dec 20175:25 pmRNSRESPONSE TO ICAP:MK RE MAX SHAREHOLDING
13th Nov 201711:22 amRNSHolding(s) in Company
8th Nov 20172:58 pmRNSDirector/PDMR Shareholding
8th Nov 20172:50 pmRNSDirector/PDMR Shareholding
8th Nov 20172:45 pmRNSDirector/PDMR Shareholding
24th Oct 201711:55 amRNSDirector/PDMR Shareholding
23rd Oct 20172:36 pmRNSResult of AGM
18th Oct 20179:34 amRNSHolding(s) in Company
17th Oct 201711:37 amRNSDirector/PDMR Shareholding
12th Oct 20179:51 amRNSDirector/PDMR Shareholding
11th Oct 20173:07 pmRNSDirector/PDMR Shareholding
10th Oct 20175:27 pmRNSHolding(s) in Company
10th Oct 201712:20 pmRNSDirector/PDMR Shareholding
9th Oct 20177:00 amRNSAGM Trading Update
3rd Oct 20174:12 pmRNSHolding(s) in Company
28th Sep 20174:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.